Atlas Trials

Evaluation of Different Types of HER2 Expression in Breast Cancer Using [99mTc]Tc -ZHER2:4107

Clinical trial NCT07292571 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT07292571
Sponsor
Tomsk National Research Medical Center of the Russian Academy of Sciences
Status
ENROLLING_BY_INVITATION
Phase
Phase 2
Study type
INTERVENTIONAL
Primary Breast Cancer
Start date
2025-10-20
Primary completion
2026-03-30
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.